Start for free
Start for free
C

Cosine

North America, New York, United States, New York

Description

A New York based biotech investment company.

Investor Profile

Cosine has made 4 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series C (25%)
  • Seed (25%)
  • Convertible Note (25%)
  • Series B (25%)

Country Focus

  • United States (75%)
  • South Korea (25%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Biopharma
  • Health Care
  • Neuroscience
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Bioinformatics
  • Machine Learning
  • Education
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cosine frequently co-invest with?

CKD Venture Capital Corporation
CKD Venture Capital Corporation
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
DRADS Capital
DRADS Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
Dolby Family Ventures
Dolby Family Ventures
North America, California, United States, San Francisco
Co-Investments: 1
IC
IBS Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
Third Kind Venture Capital
Third Kind Venture Capital
North America, New York, United States, New York
Co-Investments: 1
New York State
New York State
North America, New York, United States, New York
Co-Investments: 1
SV Angel
SV Angel
North America, California, United States, San Francisco
Co-Investments: 1
Dynamk Capital
Dynamk Capital
North America, New York, United States, New York
Co-Investments: 1
Spinnaker Capital
Spinnaker Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
Wexford Capital
Wexford Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1

What are some of recent deals done by Cosine?

Geekble

Pohang, Kyongsang-bukto, South Korea

Geekble is a media startup that produces new media content on science and technology to bridge the gap between geeks and the world.

EducationVideo
Convertible NoteJul 18, 2022
Amount Raised: $3,790,075
AZTherapies

Boston, Massachusetts, United States

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

BiopharmaBiotechnologyHealth CareNeurosciencePharmaceuticalTherapeutics
Series COct 17, 2019
Amount Raised: $26,300,000
AZTherapies

Boston, Massachusetts, United States

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

BiopharmaBiotechnologyHealth CareNeurosciencePharmaceuticalTherapeutics
Series BJun 18, 2018
Amount Raised: $23,786,003
Envisagenics

Long Island City, New York, United States

Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.

Artificial Intelligence (AI)BioinformaticsBiotechnologyMachine LearningTherapeutics
SeedNov 28, 2017
Amount Raised: $2,400,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator